ANKRD13A Antibody [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-18496G
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Applications
Immunoprecipitation, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ANKRD13A Antibody [DyLight 488]
Immunogen
Recognizes region between residues Between between 500 and 550..
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ANKRD13A Antibody [DyLight 488]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ANKRD13A
Alternate Names
ANKRD13, ankyrin repeat domain 13, ankyrin repeat domain 13A, ankyrin repeat domain-containing protein 13A, NY-REN-25, NY-REN-25 antigen, Protein KE03
Gene Symbol
ANKRD13A
Additional ANKRD13A Products
Product Documents for ANKRD13A Antibody [DyLight 488]
Product Specific Notices for ANKRD13A Antibody [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...